Kenneth C. Frazier
2009
Compensation breakdown
Change in Pension Value and Nonqualified Deferred Compensation Earnings | $1,081,703 |
---|---|
Non-Equity Incentive Plan | $1,317,459 |
Option Awards | $1,072,400 |
Salary | $1,044,688 |
Stock Awards | $459,800 |
Other | $55,919 |
Total | $5,031,969 |
Frazier received $1.3M in non-equity incentive plan, accounting for 26% of the total pay in 2009.
Frazier also received $1.1M of change in pension value and nonqualified deferred compensation earnings, $1.1M in option awards, $1M in salary, $459.8K in stock awards and $55.9K in other compensation.
Rankings
In 2009, Kenneth C. Frazier's compensation ranked 708th out of 9,885 executives tracked by ExecPay. In other words, Frazier earned more than 92.8% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 708 | 93rd |
Manufacturing | 241 | 94th |
Chemicals And Allied Products | 66 | 92nd |
Drugs | 46 | 93rd |
Pharmaceutical Preparations | 41 | 91st |
Frazier's colleagues
We found eight more compensation records of executives who worked with Kenneth C. Frazier at Merck & Co. in 2009.
2009
Robert Bertolini
Merck & Co.
Chief Financial Officer
2009
Fred Hassan
Merck & Co.
Chief Executive Officer
2009
Carrie Cox
Merck & Co.
Former Executive Vice President and President, Global Pharmaceuticals
2009
Thomas Koestler
Merck & Co.
Former Executive Vice President and President, Schering-Plough Research Institute
2009
Richard Clark
Merck & Co.
Chairman
2009
Peter Kim
Merck & Co.
Executive Vice President and President, Merck Research Laboratories
2009
Peter Kellogg
Merck & Co.
Chief Financial Officer
2009
Bruce Kuhlik
Merck & Co.